The growth of Viagra and its impact on the medicinal landscape presents a complex question for traders. While the initial sales statistics were impressive, the intellectual property has ended, leading to a flood of copycat alternatives that are eroding profit. Furthermore, the sector is facing issues related to demographic trends and changing healt